A partnership between Biovac and Pfizer-BioNTech will see locally-produced COVID-19 vaccines being distributed to African Union members from next year, but some say the target of manufacturing 100 million doses a year could be optimistic.
The Department of Social Development (DSD) is aiming to vaccinate over 240 000 of its workforce by the end of this week as South Africa enjoys an uptick in its national COVID-19 vaccination rollout during the past few days.
Scientists have been working furiously to find a vaccine against Covid-19, and initial findings show positive results from the United Kingdom trial where the vaccine was tested on 1 077 healthy adults.
South Africa is part of a ‘pariah group’ of countries not yet certified polio-free, thanks to weaknesses in our disease surveillance and vaccination programme. The Department of Health is determined to win back its certificate next month, and launched an immunisation coverage survey last week to investigate the nation’s vaccination rate.
The shortage of the BCG vaccine to protect newborns against TB is “not as grave as has been portrayed in some media quarters”, according to the National Advisory Group on Immunisation (NAGI).
HIV and tuberculosis (TB) drug stock outs have hit about 14 percent of health facilities nationwide in the last nine months, according to a new study released today by civil society coalition the Stop Stock Outs Project.
New data shows that South Africa’s expensive pneumococcal vaccine roll out has cut childhood hospitalisations due to meningitis, pneumonia and rotavirus by about 70 percent in just five years, according to Minister of Health Dr Aaron Motsoaledi.
Local experts are cautiously optimistic about last year’s cervical cancer vaccine roll-out after Australian authorities announced that vaccine is already showing positive results seven years after it was introduced in the country.